4D Molecular Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 4.92 M | $27.41 M | 1.08% | 8.86% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 4.56 M | $25.42 M | -10.49% | 8.21% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 4.27 M | $23.81 M | 19.05% | 7.70% |
| VR ADVISER, LLC | 02/14/2025 | 2.95 M | $16.44 M | -32.90% | 5.31% |
| VANGUARD GROUP INC | 02/11/2025 | 2.86 M | $15.93 M | 3.35% | 5.15% |
| BVF INC/IL | 02/14/2025 | 2.67 M | $14.88 M | -63.83% | 4.81% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 2.25 M | $12.54 M | -28.21% | 4.05% |
| NOVO HOLDINGS A/S | 02/14/2025 | 1.50 M | $8.36 M | 0.00% | 2.70% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.42 M | $7.91 M | 1,607.07% | 2.56% |
| BRAIDWELL LP | 02/14/2025 | 1.23 M | $6.83 M | 0.00% | 2.21% |
| REDMILE GROUP, LLC | 02/14/2025 | 1.20 M | $6.67 M | -5.16% | 2.15% |
| CASDIN CAPITAL, LLC | 02/14/2025 | 1.15 M | $6.41 M | 0.00% | 2.07% |
| STATE STREET CORP | 02/14/2025 | 1.11 M | $6.20 M | -47.43% | 2.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.01 M | $5.64 M | -2.35% | 1.82% |
| JPMORGAN CHASE & CO | 02/12/2025 | 820,069 | $4.57 M | 159.53% | 1.48% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 794,598 | $4.43 M | -1.11% | 1.43% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 653,530 | $3.64 M | -57.66% | 1.18% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 609,900 | $3.40 M | -85.11% | 1.10% |
| NORGES BANK | 02/12/2025 | 500,823 | $2.79 M | 100.00% | 0.90% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 02/14/2025 | 459,000 | $2.56 M | 0.00% | 0.83% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 448,831 | $2.50 M | 2,084.52% | 0.81% |
| DECHENG CAPITAL LLC | 02/14/2025 | 400,000 | $2.23 M | 0.54% | 0.72% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 313,993 | $1.75 M | 196.30% | 0.57% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 308,609 | $1.72 M | -8.78% | 0.56% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 300,000 | $1.67 M | -10.71% | 0.54% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 241,853 | $1.35 M | -69.87% | 0.44% |
| JANE STREET GROUP, LLC | 02/14/2025 | 210,824 | $1.17 M | 44.88% | 0.38% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 183,899 | $1.02 M | -36.59% | 0.33% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 177,279 | $987,444 | 6.67% | 0.32% |
| ALGERT GLOBAL LLC | 02/14/2025 | 176,778 | $985,000 | 140.72% | 0.32% |
| ENGINEERS GATE MANAGER LP | 02/14/2025 | 171,422 | $954,821 | 187.60% | 0.31% |
| PERIGON WEALTH MANAGEMENT, LLC | 01/22/2025 | 146,133 | $683,902 | -0.03% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 145,941 | $812,892 | -0.32% | 0.26% |
| 01/29/2025 | 144,743 | $806,219 | 100.00% | 0.26% | |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 131,965 | $734,607 | -36.80% | 0.24% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 126,400 | $704,048 | 451.97% | 0.23% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 123,468 | $687,717 | 0.00% | 0.22% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/11/2025 | 121,000 | $673,970 | 22.84% | 0.22% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 112,904 | $628,875 | 100.00% | 0.20% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 106,530 | $593,372 | -33.95% | 0.19% |
| BARCLAYS PLC | 02/13/2025 | 105,245 | $586,000 | -8.36% | 0.19% |
| UBS GROUP AG | 02/14/2025 | 97,564 | $543,431 | 21.52% | 0.18% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 95,424 | $531,512 | 100.00% | 0.17% |
| JUMP FINANCIAL, LLC | 02/13/2025 | 94,689 | $527,418 | 25.43% | 0.17% |
| CITIGROUP INC | 02/12/2025 | 93,621 | $521,469 | 3.56% | 0.17% |
| HRT FINANCIAL LP | 02/14/2025 | 83,419 | $464,000 | 100.00% | 0.15% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 77,813 | $433,418 | 100.00% | 0.14% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 74,400 | $414,408 | -24.70% | 0.13% |
| RHUMBLINE ADVISERS | 01/30/2025 | 73,431 | $408,998 | 5.27% | 0.13% |
| NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 71,000 | $395,470 | 0.00% | 0.13% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
4D Molecular Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 166 institutional investors and hedge funds held shares of 4D Molecular Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 4.92 M
RA CAPITAL MANAGEMENT, L.P.: 4.56 M
GOLDMAN SACHS GROUP INC: 4.27 M
VR Adviser, LLC: 2.95 M
VANGUARD GROUP INC: 2.86 M
BVF INC/IL: 2.67 M
84.35% of 4D Molecular Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 50.76 M shares in the last 24 months. This purchase volume represents approximately $322.35 M in transactions.